National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Rolapitant (Varuby®)is indicated for the prevention of delayed nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults.

 

Rapid Review

Commenced Completed Outcome
15/05/2017 12/06/2017 Full Pharmacoeconomic Evaluation Not Recommended